Ohr Pharmaceutical Inc. (OHRP) - Financial and Strategic SWOT Analysis Review

Market: Pharmaceuticals and Healthcare

United States, 25 pages report, published by GlobalData

Keywords : Ohr Pharmaceutical Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Report ThumbnailOctober-2016

Ohr Pharmaceutical Inc. (Ohr), formerly BBM Holdings, Inc. is a biopharmaceutical company that offers development of novel therapeutics and delivery technologies for the treatment of ocular diseases. The company offers products which include squalamine, trodusquemine and SKS technology products. Its squalamine products are used in wet age-related macular degeneration, retinal vein occlusion, proliferative diabetic retinopathy and diabetic macular edema indications. The company’s KSK technology products provide treatment for glaucoma, steroid induced glaucoma, eye allergy and retinal disease. It operates research facilities in San Diego. Ohr is headquartered in New York, the US.

Ohr Pharmaceutical Inc. Key Recent Developments

Aug 09, 2016: Ohr Pharmaceutical Reports Third Quarter 2016 Financial and Business Results
May 10, 2016: Ohr Pharmaceutical Reports Second Quarter 2016 Financial and Business Results
Feb 09, 2016: Ohr Pharmaceutical Reports First Quarter 2016 Financial and Business Results
Dec 10, 2015: Ohr Pharmaceutical Reports Fiscal Year 2015 Financial and Business Results
Dec 03, 2015: Ohr Pharmaceutical Announces Positive Preclinical Data in SKS Sustained Release Ocular Program

This comprehensive SWOT profile of Ohr Pharmaceutical Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ohr Pharmaceutical Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • List of Figures
  • Ohr Pharmaceutical Inc., Performance Chart
  • Ohr Pharmaceutical Inc., Ratio Charts
  • List of Tables
  • Ohr Pharmaceutical Inc., Key Information
  • Ohr Pharmaceutical Inc., Key Ratios
  • Ohr Pharmaceutical Inc., Share Data
  • Ohr Pharmaceutical Inc., Major Products and Services
  • Ohr Pharmaceutical Inc., History
  • Ohr Pharmaceutical Inc., Key Employees
  • Ohr Pharmaceutical Inc., Key Employee Biographies
  • Ohr Pharmaceutical Inc., Key Operational Heads
  • Ohr Pharmaceutical Inc., Other Locations
  • Ohr Pharmaceutical Inc., Subsidiaries
  • Ohr Pharmaceutical Inc., Key Manufacturing facilities
  • Ohr Pharmaceutical Inc., Key Competitors
  • Ohr Pharmaceutical Inc., SWOT Analysis
  • Ohr Pharmaceutical Inc., Ratios based on current share price
  • Ohr Pharmaceutical Inc., Annual Ratios
  • Ohr Pharmaceutical Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • Table of Contents
  • Section 1 - About the Company
  • Ohr Pharmaceutical Inc. - Key Information
  • Ohr Pharmaceutical Inc. - Overview
  • Ohr Pharmaceutical Inc. - Key Employees
  • Ohr Pharmaceutical Inc. - Key Employee Biographies
  • Ohr Pharmaceutical Inc. - Key Operational Heads
  • Ohr Pharmaceutical Inc. - Major Products and Services
  • Ohr Pharmaceutical Inc. - History
  • Ohr Pharmaceutical Inc. - Company Statement
  • Ohr Pharmaceutical Inc. - Locations And Subsidiaries
  • Ohr Pharmaceutical Inc. - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • Ohr Pharmaceutical Inc. - Business Description
  • Ohr Pharmaceutical Inc. - Corporate Strategy
  • Ohr Pharmaceutical Inc. - SWOT Analysis
  • SWOT Analysis - Overview
  • Ohr Pharmaceutical Inc. - Strengths
  • Ohr Pharmaceutical Inc. - Weaknesses
  • Ohr Pharmaceutical Inc. - Opportunities
  • Ohr Pharmaceutical Inc. - Threats
  • Ohr Pharmaceutical Inc. - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • Ohr Pharmaceutical Inc. - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company

Please select a license type


Related Products

GlobalDataOhr Pharmaceutical Inc. (OHRP) - Financial and Strategic SWOT Analysis ReviewProduct ThumbnailOhr Pharmaceutical Inc. (OHRP) - Financial and Strategic SWOT Analysis Review, Company ReportProduct #: 45951
Global Markets Direct
GBI Research
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved